Form 4: Medpace Holdings Director Fred B. Davenport Jr. Reports Stock Option Grant

Director Fred B. Davenport Jr. of Medpace Holdings, Inc. reports the acquisition of stock options.

Summary

• On May 17, 2024, Fred B. Davenport Jr., a director of Medpace Holdings, Inc., reported a transaction involving derivative securities.
• Davenport acquired 953 stock options with an exercise price of $393.3.
• These options vest on the earlier of the day before the first annual meeting following the grant date or the first anniversary of the grant date, contingent upon continued service on the board.
• Davenport also indirectly owns 2,000 shares of common stock through a trust.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard regulatory filing reporting a stock option grant. It doesn't inherently indicate positive or negative sentiment.

Positives

• The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the compensation and equity ownership of company directors.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it relates to potential dilution from the exercise of stock options in the future.
• The transaction has a minor impact on employees as it relates to potential dilution from the exercise of stock options in the future.

Key Dates